The Second Affiliated Hospital of Shandong First Medical University

Taian, Shandong 271099

2 studies enrolling now · 3 studies all time

What they study most

Advanced Solid Tumor, Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors — Recruiting now
• A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling